With reference to the stock exchange notification regarding Photocure's agreement with Salix Pharmaceuticals for Lumacan(TM), Wednesday October 20th 2010, Photocure is hereby inviting to a press and analyst conference to present the transaction in more detail. The presentation is open for all interested and will be held in Norwegian.
The presentation will take place today, at 01.00 pm CET at Shippingklubben, Haakon VIIs gate 1 (top floor), Oslo, Norway.
The presentation will be made by Kjetil Hestdal, President and CEO.
Best regards,
Photocure ASA
Christian Fekete, CFO
E-mail: cf@photocure.no
Mobile: +47 916 42 938
Office: +47 22 06 22 10
www.photocure.com
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)